2家供應商在售
|
||||||
商品名稱 | 規格 | 代理級別 | 價格 | 運費 | 供應商 | 購買 |
SET7/SET9 Antibody
交貨周期:現貨
|
20 μl | 經銷 |
登錄可見
|
- |
北京敏泰元科技有限公司 |
庫存:20
|
CST 2813T SET7/SET9 Antibody
交貨周期:部分現貨,期貨3-4周左右,優質售后
|
20μl | 經銷 |
登錄可見
|
- |
上海優寧維生物科技股份有限公司 |
庫存:999
|
REACTIVITY | H M R Mk |
SENSITIVITY | Endogenous |
MW (kDa) | 48 |
SOURCE | Rabbit |
Application | Dilution |
---|---|
Western Blotting | 1:1000 |
Immunofluorescence (Immunocytochemistry) | 1:25 |
Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 μg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.
SET7/SET9 Antibody detects endogenous levels of total SET7/SET9 protein. This antibody does not cross-react with other SET domain-containing proteins.
Human, Mouse, Rat, Monkey
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to the human SET7/SET9 protein. Antibodies are purified by protein A and peptide affinity chromatography.
SET7/SET9 is a member of the SET domain-containing family, and can specifically methylate Lys4 on histone H3 (1). Like most other lysine-directed histone methyltransferases, it contains a conserved catalytic SET domain originally identified in the Drosophila Su(var)3-9, Enhancer of zeste and Trithorax proteins. Histone methylation is a major determinant for the formation of active and inactive regions of the genome and is crucial for the proper programming of the genome during development (2,3). Methylation of histone H3 Lys4 enhances transcriptional activation by coordinating the recruitment of BPTF, a component of the NURF chromatin remodeling complex, and WDR5, a component of multiple histone methyltransferase complexes (4,5). In addition, methylation of lysine 4 blocks transcriptional repression by inhibiting the binding of the NURD histone deacetylation complex to the amino-terminal tail of histone H3 and interfering with SUV39H1-mediated methylation of histone H3 Lys9 (1). SET7/SET9 is highly active on free histone H3, but only very weakly methylates H3 within nucleosomes (1). Besides histones, SET7/SET9 also methylates Lys189 of the TAF10, a member of the TFIID transcription factor complex, and Lys372 of the p53 tumor suppressor protein (6,7). Methylation of TAF10 stimulates transcription in a promoter-specific manner by increasing the affinity of TAF10 for RNA polymerase II, which may potentiate pre-initiation complex formation (6). Methylation of p53 at Lys372 increases protein stability and leads to upregulation of target genes such as p21. Thus the loss of SET7/SET9 may represent another mechanism for the inactivation of p53 in human cancers (7).
京公網安備 11010802025067號 增值電信業務經營許可證:京B2-20171454 ICP備案號:京ICP備16050672號-1
喀斯瑪科技版權所有 2017-
藥品醫療器械網絡信息服務備案: (京)-網藥械信息備字(2022)第00393號
醫療器械網絡交易服務第三方平臺備案編號:京網械平臺備字(2021)第00006號